Medical Director for
COVID Testing Labs

Post-Pandemic Compliance

Why COVID Testing Labs Still Require a Medical Director

COVID testing laboratories continue to operate in a highly regulated environment, regardless of whether they perform PCR testing, rapid antigen testing, or broader respiratory panel testing. Every COVID testing laboratory must maintain an appropriate CLIA certificate, designate a qualified laboratory director, and satisfy all applicable compliance requirements that apply to its complexity level.

  • COVID Testing Labs Must Maintain CLIA Compliance: Any laboratory performing COVID-19 testing, including PCR, NAAT, antigen, or antibody testing, must hold the appropriate CLIA certificate and designate a qualified laboratory director.
  • COVID Tests Are Not All Classified the Same: Most rapid antigen tests are classified as waived when performed according to manufacturer instructions, although some may fall into moderate-complexity or high-complexity categories. PCR and NAAT-based COVID testing typically requires a laboratory director who meets the high-complexity qualification standards under CLIA.
  • The Risks of Operating Without a Qualified Director: Laboratories that operate without an appropriately qualified director may face condition-level CLIA citations, certificate suspension, or revocation.
  • Post-PHE Compliance Gaps Are Common: Many organizations focused on pandemic response and now find themselves navigating COVID lab compliance post-pandemic for the first time under full CLIA enforcement.

For laboratories performing ongoing COVID-19 and respiratory pathogen testing, a qualified medical director for SARS-CoV-2 testing is not optional. It is a foundational compliance requirement.

What Is a Medical Director for a COVID Testing Lab?

A medical director for COVID testing labs is a licensed MD or DO who serves as the laboratory’s designated CLIA laboratory director and is responsible for the laboratory’s overall operation, compliance, and quality management.

  • The CLIA Compliance Anchor: One of the medical director’s primary responsibilities is ensuring the laboratory continuously meets CLIA requirements under the standard post-PHE regulatory framework.
  • The Clinical Authority: The medical director also provides clinical oversight for the laboratory’s COVID testing operations. Responsibilities may include reviewing test authorizations, overseeing result reporting workflows, and establishing protocols for public health reporting obligations.
  • Additional Requirements for High-Complexity COVID Testing: COVID laboratories performing PCR, NAAT, or other high-complexity testing may require a laboratory director who meets the board certification or doctoral-level experience requirements under CLIA §493.1443.
  • The CLIA Compliance Anchor: One of the medical director’s primary responsibilities is ensuring the laboratory continuously meets CLIA requirements under the standard post-PHE regulatory framework.
  • The Clinical Authority: The medical director also provides clinical oversight for the laboratory’s COVID testing operations. Responsibilities may include reviewing test authorizations, overseeing result reporting workflows, and establishing protocols for public health reporting obligations.
  • Additional Requirements for High-Complexity COVID Testing: COVID laboratories performing PCR, NAAT, or other high-complexity testing may require a laboratory director who meets the board certification or doctoral-level experience requirements under CLIA §493.1443.

About the Role

Post-Pandemic CLIA Compliance for COVID Testing Labs

A medical director for COVID testing labs is a licensed MD or DO who serves as the laboratory’s designated CLIA laboratory director. The role carries full director-level accountability under federal CLIA regulations and must be performed by a physician who meets the qualification standards applicable to the laboratory’s testing complexity level.

COVID Test Method Oversight & EUA/FDA Clearance Compliance

The medical director oversees the laboratory’s COVID testing methodologies to ensure they are performed according to applicable FDA Emergency Use Authorization (EUA) instructions or cleared/approved labeling. This includes monitoring changes in testing platform authorization status and ensuring laboratory workflows remain aligned with current regulatory requirements.

CLIA Compliance, Test Complexity Assessment & Certificate Management

The medical director is responsible for ensuring the laboratory’s CLIA certificate category matches the complexity of its testing operations. For laboratories that have expanded from COVID-only to broader respiratory panel testing, the director helps evaluate complexity classifications and ensure certificate categories remain appropriate.

Quality Control, Proficiency Testing & Performance Monitoring

The medical director oversees quality control programs designed to monitor testing accuracy and reliability across all platforms. This includes overseeing proficiency testing enrollment and performance, implementing corrective actions for QC failures, and ensuring documentation standards are maintained.

Result Reporting, Turnaround Time Standards & Clinical Accuracy

Accurate and timely result reporting remains a critical responsibility. The medical director establishes policies for reporting positive, negative, and indeterminate results, turnaround time commitments, and processes for managing discrepant or out-of-range results.

Personnel Qualification, Training & Competency Assessment

CLIA requires laboratories to ensure testing personnel meet qualification standards appropriate to the complexity of testing performed. The medical director oversees personnel qualification reviews, training programs, and competency assessments, ensuring all staff performing COVID and respiratory testing meet applicable requirements.

Respiratory Panel Expansion & Multi-Pathogen Test Oversight

Many COVID testing laboratories have expanded their services to include broader respiratory panels covering influenza, RSV, adenovirus, and other respiratory pathogens. The medical director provides oversight for the addition of new tests, including validation review, complexity assessment, and quality management integration.

Public Health Reporting & Infectious Disease Notification Compliance

COVID testing laboratories may remain subject to state, local, and program-specific reporting requirements even after the end of the federal PHE. The medical director helps establish reporting workflows, result notification policies, and documentation standards that support applicable infectious disease reporting obligations.

Types of Labs We Support

Types of COVID Testing Labs We Support

Medical Director Co. supports a wide range of COVID testing laboratories and testing programs, from traditional molecular diagnostic facilities to point-of-care testing programs, occupational health facilities, and telehealth-integrated testing operations.

PCR & NAAT-Based COVID Testing Laboratories

PCR and other nucleic acid amplification testing (NAAT) platforms remain among the most sensitive methods for detecting SARS-CoV-2 and other respiratory pathogens. These laboratories typically operate under high-complexity CLIA certification and require a qualified director meeting applicable qualification standards.

Rapid Antigen & Point-of-Care COVID Testing Facilities

Rapid antigen testing programs are commonly operated by pharmacies, urgent care centers, occupational health providers, and community health organizations. Many of these programs perform waived testing, though some antigen platforms may carry moderate-complexity classifications.

Combination Respiratory Panel Laboratories (COVID + Flu + RSV)

Many laboratories have expanded beyond COVID-only testing to offer combined respiratory pathogen panels that detect influenza, RSV, and other respiratory viruses alongside SARS-CoV-2. These expanded testing menus may introduce new complexity classifications, validation requirements, and oversight obligations.

Employer & Occupational Health COVID Testing Programs

Employers, occupational health providers, and workforce health programs continue to use COVID testing as part of broader employee health and safety initiatives. Many of these programs operate under waived or moderate-complexity CLIA frameworks.

Travel, Event & High-Volume Community COVID Testing Labs

Some laboratories continue to provide testing services for community health initiatives, travel-related screening, event operations, and other high-volume scenarios. These programs often face unique operational and compliance considerations related to volume, turnaround time, and reporting obligations.

Telehealth-Integrated & At-Home COVID Testing Programs

Telehealth-enabled testing models often combine at-home specimen collection with laboratory-based analysis and electronic result delivery. These programs require careful attention to CLIA compliance, result reporting workflows, and applicable telehealth regulations.

Post-PHE Compliance

Post-Pandemic CLIA Compliance for COVID Testing Labs

Many COVID testing laboratories were established or expanded during the public health emergency (PHE), when temporary regulatory flexibilities reduced compliance burdens. With the conclusion of the federal PHE, those accommodations have been withdrawn, and laboratories are now held to standard CLIA requirements.

Key Post-PHE Compliance Areas

End of PHE Waivers & Restoration of Full CLIA Requirements

During the COVID-19 public health emergency, CMS implemented a variety of temporary flexibilities affecting laboratory operations, including accommodations related to proficiency testing, personnel qualifications, and certain documentation requirements. COVID testing laboratories that relied on PHE-era accommodations should verify that they now meet all standard CLIA requirements, and that any gaps identified during PHE operations have been addressed.

CLIA Certificate Category & Complexity Level Assessment

COVID testing laboratories should periodically evaluate whether their CLIA certificate category aligns with the complexity of the testing they currently perform. Many laboratories have also expanded beyond COVID-only testing by adding flu, RSV, or broader respiratory pathogen panels. As testing menus evolve, the applicable complexity classification and director qualification requirements may change.

Public Health Reporting Obligations & Medical Director Accountability

Although the federal public health emergency has ended, many COVID testing laboratories remain subject to state and local public health reporting requirements. The medical director is responsible for overseeing policies related to electronic laboratory reporting (ELR), result turnaround time standards, and infectious disease notification obligations that may continue to apply even after federal PHE-era reporting mandates have changed.

Core Responsibilities

Core Responsibilities of a COVID Testing Lab Medical Director

A COVID testing lab medical director is responsible for the full range of laboratory director duties required under CLIA §493.1445. These responsibilities apply regardless of whether the laboratory performs waived, moderate-complexity, or high-complexity COVID testing.

Medical Director Engagement Models for COVID Testing Labs

COVID testing laboratories vary significantly in size, testing complexity, and operational structure. A small point-of-care testing facility and a high-volume PCR laboratory have different oversight needs, and the appropriate medical director engagement model should reflect those differences.

Remote Medical Director for COVID Testing Labs

The remote oversight model is the most common arrangement for COVID testing laboratories and respiratory pathogen testing programs. Under this model, the medical director fulfills all required CLIA §493.1445 responsibilities without needing to be physically present at the laboratory on a daily basis.

For COVID testing laboratories, the director also monitors the authorization status of testing platforms, reviews changes affecting testing workflows, and provides guidance on post-PHE compliance activities.

On-Site or Hybrid Medical Director for High-Volume COVID Labs

Larger PCR testing laboratories, high-volume respiratory panel facilities, and laboratories operating under increased regulatory scrutiny may benefit from more direct physician involvement.

The medical director may participate in reviews of quality control trends, instrument maintenance documentation, proficiency testing performance, personnel competency records, and inspection preparation activities.

Interim or Emergency COVID Testing Lab Medical Director

The unexpected loss of a laboratory director can create immediate compliance challenges for a COVID testing operation. An interim medical director can provide essential coverage while a permanent solution is identified.

Medical Director Co. specializes in emergency COVID lab director replacement, often matching laboratories with qualified physicians within 24 hours.

Pricing

How Much Does a Medical Director for a COVID Testing Lab Cost?

The cost of a medical director for a COVID testing laboratory depends on the scope of oversight required, the complexity of the testing performed, the laboratory’s operational structure, and any post-PHE compliance remediation needs.

Key factors that influence pricing include:

  • CLIA complexity level: Waived, moderate-complexity, and high-complexity laboratories have different director qualification requirements, and oversight responsibilities scale accordingly.
  • Testing methodology: PCR and NAAT-based testing, rapid antigen testing, and multi-pathogen respiratory panels each carry different oversight, validation, and compliance considerations.
  • Engagement model: Remote, hybrid, and on-site arrangements require different levels of physician participation and availability.
  • Testing volume: Higher testing volumes often increase quality control, proficiency testing, documentation, and oversight responsibilities.
  • Post-PHE compliance remediation: Laboratories may require assistance with proficiency testing enrollment, personnel qualification reviews, documentation updates, and compliance gap remediation.
  • Public health reporting requirements: Reporting obligations can vary depending on the laboratory’s testing programs, jurisdictions served, and applicable state and local requirements.
  • Number of CLIA sites and states covered: Multi-site and multi-state operations typically require broader oversight and administrative coordination.
  • Urgency of placement: Emergency replacement situations may require accelerated physician sourcing and onboarding.

A qualified medical director is not simply a regulatory requirement. It is a critical investment in the laboratory’s compliance, credibility, and long-term viability.

Hiring Checklist

How to Hire a Medical Director for a COVID Testing Lab

Understanding how to hire a medical director for a COVID testing lab starts with identifying the qualifications and experience required for your specific laboratory model and testing complexity level.

1. Determine Your CLIA Complexity Level

Review the complexity classification of your COVID and respiratory testing menu to identify the appropriate director qualification standard. Waived, moderate-complexity, and high-complexity laboratories have different requirements.

2. Verify High-Complexity Qualifications When Applicable

If your laboratory performs high-complexity PCR, NAAT, or other high-complexity testing, ensure the physician meets applicable board certification or experience requirements under CLIA §493.1443.

3. Confirm State Medical Licensure

Verify that the physician holds an active medical license in every state where your laboratory’s CLIA certificate is registered.

4. Assess Infectious Disease Testing Experience

Look for experience with molecular respiratory pathogen testing, COVID testing workflows, post-PHE compliance challenges, quality management, and infectious disease testing operations.

5. Review Professional Liability Coverage

Confirm the physician carries malpractice or professional liability coverage appropriate for laboratory director responsibilities.

6. Evaluate Availability and Responsiveness

The physician should be available to support quality control review, proficiency testing attestation, regulatory changes, and post-PHE remediation activities as needed.

7. Review the Director Agreement Carefully

Agreements should clearly define §493.1445 responsibilities, reporting oversight expectations, public health reporting obligations, and post-PHE compliance activities.

8. Confirm CLIA Onboarding Readiness

Ensure the physician can be formally added to the laboratory’s CLIA documentation without unnecessary delay. Medical Director Co. simplifies this process by providing access to specialty-vetted physicians with laboratory medicine and infectious disease testing experience.

Benefits

Benefits of Having a Qualified Medical Director for Your COVID Testing Lab

A qualified medical director provides more than regulatory oversight. In the post-pandemic environment, the right physician helps COVID testing laboratories navigate CLIA compliance, address post-PHE compliance gaps, and position themselves for long-term operational sustainability.

Maintains CLIA Certification and Billing Eligibility

Helps ensure ongoing compliance with laboratory regulations that support uninterrupted testing operations and billing eligibility.

Supports Post-PHE Compliance Readiness

Identifies and addresses compliance gaps that may have developed during the transition from emergency to standard CLIA enforcement, including proficiency testing, personnel qualifications, and documentation requirements.

Strengthens Proficiency Testing Compliance

Helps ensure appropriate PT enrollment, performance monitoring, and documentation for all testing performed by the laboratory.

Keeps Documentation Current and Inspection-Ready

Supports regular review of SOPs, personnel qualification records, competency assessments, and compliance documentation to maintain inspection readiness.

Improves Public Health Reporting Compliance

Oversees reporting policies and workflows designed to meet applicable state, local, and program-specific infectious disease reporting obligations.

Provides Clinical Leadership for Evolving Testing Programs

Serves as a resource for decisions involving new testing platforms, respiratory panel expansion, complexity assessments, and evolving authorization requirements.

Enhances Credibility with Providers and Clients

Well-maintained quality systems and documentation help demonstrate reliability to ordering providers, health system partners, and public health agencies.

Creates a Stable Foundation for Future Growth

Supports laboratories as the market continues to shift from pandemic-driven testing to long-term respiratory pathogen surveillance and infectious disease testing programs. A strong medical director relationship helps position a COVID testing laboratory for ongoing compliance, operational stability, and sustainable growth.

Who We Serve

COVID Testing Lab Medical Director Services — Who We Serve

Medical Director Co. supports a wide range of COVID testing laboratories and testing programs, helping organizations maintain compliance, address post-PHE compliance gaps, and support long-term operational stability.

Independent COVID & Respiratory Panel Testing Labs

Many standalone COVID testing laboratories were established rapidly during the pandemic and have since expanded into broader respiratory panel testing. These organizations often benefit from physician oversight that supports post-PHE compliance review, proficiency testing management, and test menu expansion.

Urgent Care & Retail Health COVID Testing Programs

Urgent care centers, pharmacy-based clinics, and retail health providers often perform waived or moderate-complexity COVID testing as part of broader primary care services. A qualified medical director helps ensure CLIA compliance and documentation standards are maintained.

Occupational Health & Employer COVID Testing Facilities

Employer-sponsored testing programs and occupational health providers continue to use COVID testing as part of broader workforce health and safety initiatives. Medical director oversight supports CLIA compliance, quality management, and reporting obligations.

Telehealth Companies with CLIA-Certified Testing Partners

Telehealth platforms frequently integrate COVID testing into virtual care workflows through affiliated CLIA-certified laboratories. These arrangements require careful attention to physician oversight, result reporting, CLIA compliance, and applicable telehealth regulations.

New Infectious Disease Testing Labs Expanding Beyond COVID

Many laboratories are using their COVID testing infrastructure as a foundation for broader infectious disease testing programs. Expanding the test menu introduces new CLIA requirements, complexity considerations, and physician oversight obligations.

Common Challenges & Solutions

Common Challenges for COVID Testing Labs & Solutions

COVID testing laboratories continue to face unique operational and regulatory challenges as the industry transitions from emergency-era operations to standard post-PHE CLIA enforcement.

Discovering Post-PHE Compliance Gaps

Many COVID testing laboratories benefited from temporary flexibilities during the public health emergency and are only now identifying compliance gaps under standard CLIA requirements. Medical Director Co. helps laboratories conduct post-PHE compliance reviews and implement remediation plans.

Keeping Up with Rapidly Changing COVID Test Authorizations

COVID testing regulations, testing platform authorizations, public health reporting requirements, and respiratory testing guidance continue to evolve. A qualified medical director helps laboratories stay current with regulatory changes and adapt workflows accordingly.

Enrolling in Proficiency Testing Programs After PHE PT Waivers Expired

Some laboratories that launched during the pandemic have limited experience with traditional proficiency testing requirements. Medical Director Co. connects laboratories with directors who can support PT enrollment, performance monitoring, and corrective action planning.

Evolving the Lab's Test Menu from COVID-Only to Respiratory Panel Testing

Expanding from SARS-CoV-2 testing into broader respiratory pathogen panels introduces new validation, reporting, quality management, and complexity assessment requirements. A medical director provides the oversight needed to navigate this transition compliantly.

Replacing a COVID Testing Lab Director Quickly When One Departs

An unexpected laboratory director departure can create immediate compliance concerns and operational uncertainty. Medical Director Co. specializes in emergency placement for COVID testing laboratories, often matching organizations with qualified physicians within 24 hours.

Why Choose Us

Why Choose Medical Director Co. for Your COVID Testing Lab?

COVID testing laboratories face a unique combination of CLIA, public health reporting, and post-pandemic compliance challenges. Medical Director Co. delivers more than physician placement. We provide a long-term compliance partnership designed to help COVID and respiratory testing laboratories operate safely, maintain certification, and adapt to an evolving regulatory environment.

COVID Testing Laboratory Expertise

We have supported COVID and respiratory testing laboratories throughout the pandemic and the transition to post-PHE compliance. Our network includes physicians familiar with COVID testing workflows, PCR laboratory operations, antigen testing programs, and post-PHE compliance requirements.

Fast Placement When Timing Matters

We can often identify qualified candidates within 12 to 24 hours, helping laboratories address compliance gaps, director vacancies, and regulatory deadlines without unnecessary delay.

Nationwide Physician Network

Medical Director Co. supports laboratories in all 50 states with physicians experienced in COVID testing compliance, respiratory panel operations, and post-PHE regulatory environments.

Compliance-First Physician Vetting

Every physician is evaluated against the qualification requirements applicable to the laboratory’s CLIA complexity level, ensuring directors meet applicable federal and state standards before placement.

Post-PHE Compliance Remediation Support

Many laboratories are still working through compliance gaps created during the transition from emergency to standard CLIA enforcement. Our physician partners can help identify and address these gaps as part of their ongoing oversight activities.

Ongoing Regulatory Monitoring

Our physician partners stay informed about changes affecting COVID testing, respiratory pathogen testing, public health reporting, and CLIA requirements, providing laboratories with a physician who can adapt oversight activities as the regulatory environment evolves.

Service Areas

Nationwide COVID Testing Lab Medical Director Coverage

Medical Director Co. provides medical director placement services for COVID testing laboratories in all 50 states. Physician matching, complexity qualification verification, and onboarding support are available nationwide.

States such as New York, California, Florida, Texas, and others maintain robust laboratory oversight and reporting requirements that may go beyond federal CLIA standards. Our team accounts for state-specific compliance obligations during the matching and onboarding process.

State Coverage Directory

Select your state to learn more about COVID testing laboratory oversight requirements, CLIA compliance considerations, and medical director qualifications in your jurisdiction.

Our Nationwide Coverage Includes:

States We Serve:

From standalone COVID testing laboratories and respiratory panel facilities to occupational health programs, urgent care networks, telehealth testing platforms, and emerging infectious disease laboratories, Medical Director Co. provides physician oversight solutions tailored to the post-PHE compliance environment.

Onboarding Process

The Onboarding Process for COVID Testing Labs

Medical Director Co. follows a structured onboarding process designed to help COVID testing laboratories secure qualified physician oversight quickly and efficiently.

1. COVID Testing Lab Compliance Assessment

We begin with a comprehensive review of your laboratory’s CLIA certificate status, testing complexity level, COVID and respiratory testing menu, proficiency testing enrollment, and any post-PHE compliance gaps that may require attention.

2. Physician Matching for Infectious Disease Testing

Our team identifies qualified physicians whose credentials, laboratory experience, infectious disease testing background, and state licensure align with your laboratory’s compliance profile and operational needs.

3. Credential Verification & CLIA Compliance Screening

Every candidate undergoes a detailed verification process that includes state license review, board certification confirmation where required, professional liability coverage assessment, and evaluation of relevant COVID and respiratory testing laboratory experience.

4. Medical Director Agreement Execution

Once a physician is selected, we facilitate a formal agreement that clearly defines CLIA §493.1445 responsibilities, proficiency testing oversight, public health reporting obligations, and post-PHE compliance activities.

5. CLIA Documentation & Post-PHE Remediation Onboarding

The physician is integrated into the laboratory’s CLIA compliance framework and applicable documentation. An initial compliance review may be conducted to identify any remaining post-PHE remediation needs and establish a plan for addressing them.

6. Ongoing Oversight & Regulatory Monitoring

Following onboarding, we establish an ongoing engagement schedule that supports quality control review, proficiency testing attestation, regulatory monitoring, public health reporting oversight, and any compliance activities that may arise as COVID and respiratory testing regulations continue to evolve.

Success Stories

Case Study / Success Story

The following examples are representative composite case studies based on common COVID testing laboratory engagement scenarios.

“A high-volume COVID PCR laboratory launched during the public health emergency and operated successfully throughout the pandemic. After the PHE concluded, the laboratory identified significant post-PHE compliance gaps including lapsed proficiency testing enrollment and outdated personnel qualification documentation. Medical Director Co. placed a qualified physician within 48 hours who helped the laboratory conduct a comprehensive compliance review and develop a remediation plan.”

High-Volume PCR Testing Laboratory

Illinois

“A laboratory that initially focused on SARS-CoV-2 testing decided to expand into influenza, RSV, and broader respiratory pathogen testing. The expansion required complexity reassessment, new test validation oversight, and updated proficiency testing enrollment. Medical Director Co. connected the laboratory with a physician experienced in multi-pathogen respiratory panel operations who helped guide the transition.”

Independent COVID & Respiratory Panel Laboratory

North Carolina

“A community testing laboratory supporting employer screening programs experienced the unexpected departure of its laboratory director. Facing compliance concerns and operational uncertainty, the organization contacted Medical Director Co. and was matched with a qualified interim physician within 24 hours, allowing testing operations to continue without interruption.”

Community Testing & Occupational Health Laboratory

Colorado

FAQs

Frequently Asked Questions

Yes. The end of the federal public health emergency (PHE) on May 11, 2023 did not eliminate CLIA requirements for COVID testing laboratories. Every laboratory performing COVID-19 testing must maintain an appropriate CLIA certificate and designate a qualified laboratory director who meets the applicable qualification standards for the laboratory’s complexity level.

COVID testing laboratories are now subject to standard CLIA requirements based on the complexity of the testing they perform. This includes full proficiency testing compliance, standard personnel qualification standards, quality control requirements, documentation standards, and all other applicable CLIA conditions of participation.

The required qualifications depend on the laboratory’s testing complexity classification. For high-complexity PCR and NAAT testing, the laboratory director must meet the qualification requirements under CLIA §493.1443, which may include board certification in a relevant specialty or doctoral-level experience in laboratory science.

Yes. CLIA permits remote laboratory director oversight provided all required responsibilities are actively performed and appropriately documented. Remote oversight is the most common model for COVID testing laboratories of all sizes.

Operating without a qualified laboratory director can place a laboratory’s CLIA certification at risk. Because the laboratory director is a required CLIA position, operating without a qualified director can result in condition-level citations, certificate suspension, or other enforcement actions.

A post-PHE compliance review is often the best starting point. Laboratories should evaluate director qualifications, proficiency testing enrollment and performance history, personnel qualification documentation, quality control records, and public health reporting compliance.

Yes. Even laboratories performing only waived COVID antigen testing must operate under an appropriate CLIA certificate and designate a laboratory director. While waived testing carries less stringent director qualification requirements than high-complexity testing, the director designation requirement applies across all CLIA certificate types.

The medical director helps ensure the laboratory maintains policies and procedures that satisfy applicable reporting requirements. This includes overseeing electronic laboratory reporting workflows, result turnaround time standards, and infectious disease notification processes that may continue to apply under state and local requirements.

Yes. Expanding from COVID-only testing into influenza, RSV, or broader respiratory pathogen testing often requires additional validation review, complexity reassessment, proficiency testing adjustments, and quality management updates. Medical Director Co. can connect your laboratory with a physician experienced in respiratory panel operations who can provide oversight for this transition.

The process begins with a review of your laboratory’s testing menu, CLIA certificate status, testing complexity level, compliance history, and any post-PHE remediation needs. Medical Director Co. can help you identify the appropriate physician qualifications, evaluate your compliance structure, and connect you with a qualified medical director who aligns with your operational and compliance goals.

Get Started Today

Need a Medical Director for Your COVID Testing Lab?

The transition from pandemic-era regulatory flexibilities to full CLIA enforcement has created new compliance challenges for many COVID testing laboratories. Whether your organization is navigating post-PHE compliance gaps, expanding into respiratory panel testing, replacing a departing director, or simply looking for reliable physician oversight, Medical Director Co. is here to help.

Medical Director Co. has helped hundreds of laboratories navigate the post-PHE compliance environment and can match your organization with a qualified medical director quickly and efficiently.

Hire a Medical Director or
Collaborating Physician Today

Scroll to Top

Get Matched Today
and Save $200

We'll contact you within 30 minutes.

Select your clinic type and we’ll match you with the right physician — fast.

Medspa/Aesthetics

Weight Loss

IV/Wellness

Telehealth

Other

Your clinic type:

Medspa/Aesthetics
Change Clinic Type

You're on your way!

We received your request for a physician.
Our team will contact you soon.